Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06701955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease

Study acronym: EFN-RETEST
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Nov 1, 2026 → Feb 1, 2027
See other at-risk trials from University Hospital, Grenoble

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Nov 1, 2026 to Feb 1, 2027 Show 4 more changesShow less
    • Study completion date: Mar 1, 2027 to Feb 1, 2027
    • Start date changed from estimate of Feb 1, 2025 to Jan 30, 2025
    • Eligibility criteria expanded, about 10 words
    • Study title revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 1, 2024 to Feb 1, 2025
    • Site details revised
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study focuses on neuropsychiatric fluctuations (NPF) in Parkinson's disease. Due to the lack of specific assessment tools, we developed the Neuropsychological Fluctuations Scale (NFS), a 20-item questionnaire. Recent studies have confirmed its reliability, sensitivity, and validity. To finalize its validation, assessing its test-retest reliability is an essential next step.
Trial Details
NCT Number NCT06701955
Lead Sponsor University Hospital, Grenoble
Conditions
(from sponsor)
Parkinson's Disease
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov